These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6318671)

  • 21. [Current aspects of chemotaxis of phagocytic cells].
    Frobert Y; Carraz M; Veysseyre C
    Bull Eur Physiopathol Respir; 1983; 19(2):111-3. PubMed ID: 6307438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of chemotaxis and formyl peptide binding in human promyelocytic leukemia cell line (HL60).
    Wood PA; Douglas SD
    Proc Soc Exp Biol Med; 1982 Apr; 169(4):421-6. PubMed ID: 6280196
    [No Abstract]   [Full Text] [Related]  

  • 23. [Leucocyte chemotaxis and its anomalies (author's transl)].
    Pham HT
    Nouv Presse Med; 1982 Jan; 11(2):123-6. PubMed ID: 7058129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterization of a derivative of wheat germ agglutinin which specifically inhibits polymorphonuclear leukocyte chemotaxis to the synthetic chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine.
    Perez HD; Elfman F; Chenoweth D; Hooper C
    J Immunol; 1986 Mar; 136(5):1813-9. PubMed ID: 3753994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte dysfunction in severe trauma: evidence for the role of C5a in deactivation.
    Antrum RM; Solomkin JS
    Surgery; 1986 Jul; 100(1):29-37. PubMed ID: 3726758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of endotoxin-induced C5-derived chemotactic activity in aqueous humor.
    Rosenbaum JT; Wong K; Perez HD; Raymond W; Howes EL
    Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1184-91. PubMed ID: 6384121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propofol decreases random and chemotactic stimulated locomotion of human neutrophils in vitro.
    Jensen AG; Dahlgren C; Eintrei C
    Br J Anaesth; 1993 Jan; 70(1):99-100. PubMed ID: 8431346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
    Senior RM; Skogen WF; Griffin GL; Wilner GD
    J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.
    Marder SR; Chenoweth DE; Goldstein IM; Perez HD
    J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of human monocyte chemoattractant binding by flow cytometry.
    Leonard EJ; Noer K; Skeel A
    J Leukoc Biol; 1985 Sep; 38(3):403-13. PubMed ID: 3861752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin chemotactic stimulation of HL-60 cells: studies on thrombin responsiveness as a function of differentiation.
    Bar-Shavit R; Hruska KA; Kahn AJ; Wilner GD
    J Cell Physiol; 1987 May; 131(2):255-61. PubMed ID: 3034923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular mechanisms of leukocyte chemotaxis.
    Snyderman R; Goetzl EJ
    Science; 1981 Aug; 213(4510):830-7. PubMed ID: 6266014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
    Morita E; Schröder JM; Christophers E
    Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 36. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the neutrophil in oral disease: receptor deficiency in leukocytes from patients with juvenile periodontitis.
    Van Dyke TE
    Rev Infect Dis; 1985; 7(3):419-25. PubMed ID: 3895356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
    Perez HD; Elfman F; Lobo E
    J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme.
    Bender JG; McPhail LC; Van Epps DE
    J Immunol; 1983 May; 130(5):2316-23. PubMed ID: 6300243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.